ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹576 Cr | ₹452 Cr | ₹373 Cr | ₹315 Cr | ₹215 Cr |
What is the latest Net Current Assets ratio of ASTRAZENECA PHARMA INDIA ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹576 Cr |
Mar2023 | ₹452 Cr |
Mar2022 | ₹373 Cr |
Mar2021 | ₹315 Cr |
Mar2020 | ₹215 Cr |
How is Net Current Assets of ASTRAZENECA PHARMA INDIA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹576 Cr | 27.47 | |
Mar2023 | ₹452 Cr | 21.05 | |
Mar2022 | ₹373 Cr | 18.32 | |
Mar2021 | ₹315 Cr | 46.58 | |
Mar2020 | ₹215 Cr | - |
Compare Net Current Assets of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹17,844.4 Cr | 13% | 7.4% | 30.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹450,595.0 Cr | 2.6% | 4.5% | 49.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,089.0 Cr | 3.2% | -2.9% | 54.9% | Stock Analytics | |
CIPLA | ₹124,175.0 Cr | 2.8% | 1.5% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,625.0 Cr | 1.1% | 12.1% | 18.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,672.5 Cr | 1.5% | -0.1% | 41.6% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 13% |
7.4% |
30.6% |
SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses